Nine updates for World Pancreatic Cancer Day
World Pancreatic Cancer Day will be observed today.
The World Pancreatic Cancer Coalition has united more than 60 organizations from 27 countries to increase awareness about pancreatic cancer and inspire action to improve outcomes for individuals with the disease.
In conjunction with the observation, here are 10 updates related to pancreatic cancer diagnosis and treatment.
1. Researchers at Virginia Commonwealth Massey Cancer Center became the first to implant the bio-absorbable internal radiation device known as CivaSheet (CivaTech Oncology) for the treatment of early-stage pancreatic cancer. CivaSheet is a flat, flexible membrane that provides unidirectional radiation to the tumor site while shielding healthy tissue. Read more.
2. Young age, low baseline cancer antigen 19-9 and use of gemcitabine as a radiosensitizer are associated with a major pathologic response following preoperative therapy for pancreatic ductal adenocarcinoma. Read more.
3. Researchers observed germline mutations in pancreatic cancer susceptibility genes among patients with pancreatic cancer who did not have significant family history of the disease. Read more.
4. The addition of stereotactic body radiotherapy to chemotherapy extended OS among patients with unresectable pancreatic cancer. Read more.
5. Halozyme Therapeutics and Genentech initiated a multiarm clinical trial that will evaluate PEGPH20 (Halozyme Therapeutics) in combination with atezolizumab (Tecentriq, Genentech) for previously treated patients with metastatic pancreatic ductal adenocarcinoma. Read more.
6. A new trial has been launched to help researchers better understand the link between new-onset diabetes and pancreatic cancer. Researchers also hope to identify biomarkers that may allow for earlier detection of pancreatic cancer among individuals with newly diagnosed diabetes. Read more.
7. A new smartphone app called BiliScreen showed promise for pancreatic cancer screening by analyzing signs of jaundice in photos of a user’s eyes. Developers hope this tool can help facilitate earlier detection of pancreatic cancer in at-risk individuals. Read more.
8. Patients with pancreatic cancer who underwent pancreatoduodenectomy experienced shorter hospital stays with laparoscopic surgery than open surgery, according to results of a randomized controlled trial. Read more.
9. A novel genetic testing strategy that sequences mutations in pancreatic cyst fluid before surgery showed high accuracy for identifying cysts associated with a high risk for aggressive pancreatic cancer. Read more.